Survey Assessing How Consumers Adapt Their Diet in Response to Health Claim Messaging

November 26, 2024 updated by: Dr. Heather Blewett, St. Boniface Hospital
A survey designed to examine how consumers adapt their diet in response to health claim messaging.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

384 participants will be recruited to participate (n=32/group) ensuring equal numbers based on gender (men and women), income (low and medium-high), and age (18-35, 36-55, >56 years). Participants will be asked to prepare a 3-day food record representative of their current dietary intake. Participants will then be told, "Health Canada has approved the following health claim: 40g of ground flaxseed per day has been shown to help lower cholesterol, which is a risk factor for heart disease." Without any further guidance, participants will then be asked to modify their diet to achieve 40g per day of flaxseeds for the following 2 weeks. They will be asked to prepare another 3-day food record so we can see if/how their diet changed. At the end of the 2-week period, participants will be asked if they were successful with the changes and what barriers they faced in implementing these changes. This survey will be accomplished remotely with informed consent and communication with participants happening over the phone or videoconference. Participants will mail the food records to clinical trial staff. Analysis of food records will identify the food choices used to achieve dietary change, if these changes altered nutrient intake compared to their usual diet and if they were able to achieve the target laid out (ie. 40g flaxseed per day). A questionnaire will be used to identify barriers to implementation of dietary change (ie. price, availability, sensory aspects of food, ease of preparation).

Study Type

Interventional

Enrollment (Estimated)

384

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Manitoba
      • Winnipeg, Manitoba, Canada, R2H 2A6
        • Recruiting
        • I. H. Asper Clinical Research Institute
        • Contact:
        • Contact:
          • Heather J Blewett, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Man or woman, age ≥18 years;
  2. Willing to provide informed consent;
  3. Willing/able to comply with the requirements of the study;
  4. Have a mailing address in the Winnipeg census metropolitan area (City of Winnipeg and the municipalities of West St. Paul, East St. Paul, Headingley, Macdonald, Richot, Tache, Springfield, Rosser, St. Francois Xavier and St. Clements)4.

Exclusion Criteria:

  1. Allergy, aversion or unwillingness to eat whole ground flaxseed;
  2. Consuming ≥40g whole ground flaxseed/day;
  3. A family member within the same household is participating or has participated in this study;
  4. Currently participating in a food trial or dietary program that does not allow change in food choice.
  5. Pregnant or lactating

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Implementation of health claim
Participants will have 2 weeks to incorporate 40g of flaxseed per day into their diet
40g of flaxseed per day

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
3-day food record to assess food choices to achieve health claim
Time Frame: Two weeks
A list of flax containing foods from the 3-day food record will be created and the frequency with which each food item was selected will be recorded.
Two weeks
Comparison of 3-day food records to assess change in nutrient intake from usual diet to diet addressing health claim
Time Frame: Four weeks
3 day food records before and after change in diet to address health claim will be entered into nutrition analysis software to calculate nutrient intake
Four weeks
Were they able to achieve the target laid out in the health claim
Time Frame: 2 weeks
Questionnaire to identify barriers to implementation of health claim
2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Barriers to implementation of dietary change
Time Frame: 2 weeks
Questionnaire to identify if price, availability, sensory aspects of food, ease of preparation are barriers to implementation of the health claim
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Heather Blewett, PhD, Agriculture and Agri-Food Canada

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 3, 2022

Primary Completion (Estimated)

November 1, 2025

Study Completion (Estimated)

November 1, 2025

Study Registration Dates

First Submitted

October 6, 2021

First Submitted That Met QC Criteria

October 19, 2021

First Posted (Actual)

October 22, 2021

Study Record Updates

Last Update Posted (Actual)

November 29, 2024

Last Update Submitted That Met QC Criteria

November 26, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • HS25165 (B2021:102) (Other Identifier: Biomedical research Ethics Board, University of Manitoba)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All IPD that underlie results in a publication

IPD Sharing Time Frame

From the time the data is collected until the manuscript is accepted for publication

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Claim Implementation

Clinical Trials on flaxseed

Subscribe